Valeant Pharmaceuticals International agrees to divest Paragon Holdings
MLex Summary: Canada-based Valeant Pharmaceuticals International has agreed to divest Paragon Holdings to settle Federal Trade Commission allegations that Valeant's acquisition of Paragon violated antitrust laws, according to an FTC statement...To view the full article, register now.
Already a subscriber? Click here to view full article